Study to Assess Oropharyngeal Carriage of N. Meningitidis in South Australian School Leavers
NCT03419533 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6802
Last updated 2021-11-05
Summary
This is an observational cross sectional study to evaluate the impact of a 4CMenB vaccination program on oropharyngeal N. meningitidis carriage in vaccinated and unvaccinated school leavers.
Conditions
- Neisseria Meningitidis
Sponsors & Collaborators
-
University of Adelaide
lead OTHER
Principal Investigators
-
Helen Marshall · University of Adelaide
Eligibility
- Min Age
- 17 Years
- Max Age
- 25 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-02-01
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- Australia
Study Locations
More Related Trials
-
Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children
NCT00771849 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate 4 Different Formulations of Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs
NCT00126945 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs
NCT00196963 ·Status: COMPLETED ·Phase: PHASE2
-
Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age
NCT04368429 ·Status: COMPLETED ·Phase: PHASE3
-
Understanding the Immune Response to Two Different Meningitis Vaccines
NCT01593514 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Toddlers
NCT00631995 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old
NCT02867319 ·Status: COMPLETED ·Phase: PHASE1
-
A Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of MenACWY in Adolescents and Adults in Korea
NCT01274897 ·Status: COMPLETED ·Phase: PHASE3
-
Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults
NCT00772629 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Meningococcal Conjugate Vaccine on Meningococcal Carriage
NCT00119080 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 Months
NCT05252715 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Sourcing Study to Collect Human Blood Samples From Healthy Adults
NCT03493919 ·Status: COMPLETED ·Phase: PHASE4
-
Understanding Immunity Persistence After Adolescent MenC Vaccination
NCT01459432 ·Status: COMPLETED
-
Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine
NCT01897402 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine
NCT04689191 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of the ACYW135 Meningococcal Polysaccharide Conjugate Vaccine
NCT06337071 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Clinical Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) in Adults Aged 18 to 55 Years
NCT06131554 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety & Immunogenicity of 1 Dose of GSK134612 in Children 12-14 Months and 3-5 Years Old
NCT00196976 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 18-25 Years
NCT00196950 ·Status: COMPLETED ·Phase: PHASE2
-
Persistence of Antibody Response to N. Meningitidis Group C in Children
NCT00316654 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in Volunteers Aged 3-5 Months
NCT06314659 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine
NCT00126984 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old
NCT05739292 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population.
NCT04236960 ·Status: COMPLETED ·Phase: PHASE1
-
Understanding the Immune Response to Meningitis Vaccines
NCT00901940 ·Status: COMPLETED ·Phase: PHASE3